Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001636282-26-000001

Options or other derivatives

  • King-Jones Heidy acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

King-Jones Heidy

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +140,000 140,000 D
Loading xslF345X05/wk-form4_1768357531.xml…